Neuralink begins a groundbreaking feasibility trial with its brain implant and robotic arm, aiming to advance digital and ...

TheraCryf’s highly selective Ox-1 receptor antagonist was acquired as part of its acquisition of Chronos Therapeutics Ltd in ...

A significant step forward in Lundbeck’s Focused Innovator strategy and advancing the goal of building a robust neuro-rare ...

Our client, a worldwide IVD leader is looking for someone to be responsible for all sales activities of their Transplant and Transfusion products across the South West up to Manchester. · Manage all ...

Malcolm is non-executive chairperson where his role is to help guide and shape strategy to achieve sustainable planned, ...

Our client manufactures illumination systems and fluorescence microscopy competing with mercury based systems and can make bespoke OEMs for client needs.

New StreamlineMP software suite offers specialized data analysis modules to standardize and speed up workflows in key ...

Responding to the publication of the Government’s ‘Get Britain Working’ White Paper, Christopher Rocks, lead economist for ...

MASCOT, a global phase III randomized, double-blind, placebo-controlled trial, will assess the efficacy and safety of ...